Position in ACRS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,718,211
+$800,233 QoQ
Shares Held
513,840
+0.5% QoQ
Ownership
0.349%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 149 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 75%
Shared 17%
None 8%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. ACRS ranks #128 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ACRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,718,211 | 513,840 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,917,978 | 511,461 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $815,255 | 270,850 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $312,062 | 164,244 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $294,326 | 207,273 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $542,916 | 354,849 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $594,194 | 239,595 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $88,330 | 76,810 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $84,434 | 76,759 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $110,435 | 89,061 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $196,930 | 187,553 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,792,870 | 261,733 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,041,738 | 100,457 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,115,796 | 137,923 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $756,267 | 48,017 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $755,787 | 48,017 | Shares | Sole | 2022-11-10 | |
| 2021-09-30 | $335,520 | 18,640 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $327,318 | 18,640 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $469,728 | 18,640 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $120,600 | 18,640 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $47,884 | 18,632 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $18,489 | 11,413 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $11,869 | 11,413 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||